MOESM4 of Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study

Additional File 4: Figure S2. BCVA and CSFT outcomes at Month 12 stratified by (A) presence of SRF, (B) presence of cysts and (C) thickness of cysts at baseline, for patients with month 12 BCVA data (FAS).